| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| O95406 (CNIH1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein cornichon homolog 1; Cornichon family AMPA receptor auxiliary protein 1; Protein cornichon homolog; T-cell growth-associated molecule 77; | |
| P47813 (IF1AX_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Eukaryotic translation initiation factor 1A, X-chromosomal; Eukaryotic translation initiation factor 4C; | |
| Q8WXI4 (ACO11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Acyl-coenzyme A thioesterase 11; Acyl-CoA thioester hydrolase 11; Adipose-associated thioesterase; Brown fat-inducible thioesterase; Palmitoyl-coenzyme A thioesterase; | |
| P41223 (BUD31_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein BUD31 homolog; Protein EDG-2; Protein G10 homolog; | |
| O95251 (KAT7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Histone acetyltransferase KAT7; Histone acetyltransferase binding to ORC1; Lysine acetyltransferase 7; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2; | |
| Q494U1 (PKHN1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Pleckstrin homology domain-containing family N member 1; Cardiolipin and phosphatidic acid-binding protein; | |
| Q14863 (PO6F1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | POU domain, class 6, transcription factor 1; Brain-specific homeobox/POU domain protein 5; mPOU homeobox protein; | |
| O15213 (WDR46_HUMAN) | Swiss-Prot | Homo sapiens (Human) | WD repeat-containing protein 46; WD repeat-containing protein BING4; | |
| A7MD48 (SRRM4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/arginine repetitive matrix protein 4; Medulloblastoma antigen MU-MB-2.76; Neural-specific serine/arginine repetitive splicing factor of 100 kDa; | |
| Q96PZ2 (F111A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine protease FAM111A; | |
| O94955 (RHBT3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Rho-related BTB domain-containing protein 3; | |
| P23588 (IF4B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Eukaryotic translation initiation factor 4B; | |
| P16581 (LYAM2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E-selectin; CD62 antigen-like family member E; Endothelial leukocyte adhesion molecule 1; Leukocyte-endothelial cell adhesion molecule 2; CD62E; | |
| P09960 (LKHA4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Leukotriene A-4 hydrolase; Leukotriene A(4) hydrolase; Tripeptide aminopeptidase LTA4H; | |
| P16415 (ZN823_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 823; Zinc finger protein ZFP-36; | |
| Q9H6U8 (ALG9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-1,2-mannosyltransferase ALG9; Asparagine-linked glycosylation protein 9 homolog; Disrupted in bipolar disorder protein 1; Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase; Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase; | |
| Q8IZD4 (DCP1B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | mRNA-decapping enzyme 1B; | |
| P20393 (NR1D1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Nuclear receptor subfamily 1 group D member 1; Rev-erbA-alpha; V-erbA-related protein 1; | |
| O75343 (GCYB2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Guanylate cyclase soluble subunit beta-2; | |
| A6NNF4 (ZN726_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 726; | |
| Q96B42 (TMM18_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 18; | |
| Q9Y217 (MTMR6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR6; Myotubularin-related protein 6; Phosphatidylinositol-3-phosphate phosphatase; | |
| Q9UKR5 (ERG28_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ergosterol biosynthetic protein 28 homolog; | |
| Q6ZSK4 (NTAS1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein NTM-AS1; NTM antisense RNA 1; NTM antisense gene protein 1; | |
| Q6ZQT0 (YD023_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein FLJ45035; | |
| Q6GMV3 (PTRD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative peptidyl-tRNA hydrolase PTRHD1; Peptidyl-tRNA hydrolase domain-containing protein 1; | |
| Q9NWQ9 (CN119_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C14orf119; | |
| P0DI81 (TPC2A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Trafficking protein particle complex subunit 2; Sedlin; | |
| P0DI82 (TPC2B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Trafficking protein particle complex subunit 2B; MBP-1-interacting protein 2A; | |
| A6NFH5 (FBP12_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Fatty acid-binding protein 12; | |
| O75817 (POP7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ribonuclease P protein subunit p20; Ribonucleases P/MRP protein subunit POP7 homolog; | |
| O94817 (ATG12_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ubiquitin-like protein ATG12; Autophagy-related protein 12; | |
| P51114 (FXR1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | RNA-binding protein FXR1; FMR1 autosomal homolog 1; hFXR1p; | |
| Q19AV6 (ZSWM7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger SWIM domain-containing protein 7; SWIM domain-containing and Srs2-interacting protein 1 homolog; SWIM-type zinc finger domain-containing protein 7; | |
| Q5W150 (YT011_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein MGC163334; | |
| Q56UQ5 (TPT1L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | TPT1-like protein; | |
| Q96EE4 (CC126_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Coiled-coil domain-containing protein 126; | |
| Q96CP2 (FWCH2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | FLYWCH family member 2; | |
| Q8TEV8 (SMCR5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Smith-Magenis syndrome chromosomal region candidate gene 5 protein; | |
| Q8N1V2 (CFA52_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Cilia- and flagella-associated protein 52; WD repeat-containing protein 16; WD40-repeat protein up-regulated in HCC; | |
| P35080 (PROF2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Profilin-2; Profilin II; | |
| Q15486 (GUSP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative inactive beta-glucuronidase-like protein SMA3; | |
| Q6ZVL8 (YP033_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein FLJ42384; | |
| O94772 (LY6H_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Lymphocyte antigen 6H; | |
| Q6UX40 (TM107_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 107; | |
| Q9NPJ3 (ACO13_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Acyl-coenzyme A thioesterase 13; Hotdog-fold thioesterase superfamily member 2; Palmitoyl-CoA hydrolase; Thioesterase superfamily member 2; Acyl-coenzyme A thioesterase 13, N-terminally processed; | |
| Q9H845 (ACAD9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Complex I assembly factor ACAD9, mitochondrial; Acyl-CoA dehydrogenase family member 9; | |
| Q96MC4 (C295L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CEP295 N-terminal-like protein; KIAA1731 N-terminal like protein; | |
| P55199 (ELL_HUMAN) | Swiss-Prot | Homo sapiens (Human) | RNA polymerase II elongation factor ELL; Eleven-nineteen lysine-rich leukemia protein; | |
| A6NKL6 (T200C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 200C; Transmembrane protein TTMA; Two transmembrane domain-containing family member A; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_02 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,652 | 17,815 | 43,031 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 15-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 30-mer | 32-mer | 33-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,374 | 3,279 | 317 | 620 | 61 | 135 | 14 | 51 | 2 | 21 | 8 | 46 | 1 | 5 | 2 | 22 | 8 | 2 | 1 | 2 | 17 | 2 | 2 | 1 | 3 | 1 | 1 | 2 | 1 | 7 | 1 | 5 | 1 | 1 | 13 | 2 |
